128 related articles for article (PubMed ID: 26150163)
1. Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.
Feng H; Zhang H; Deng J; Wang L; He Y; Wang S; Seyedtabaei R; Wang Q; Liu L; Galipeau J; Compans RW; Wang BZ
Sci Rep; 2015 Jul; 5():11856. PubMed ID: 26150163
[TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses.
Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H
Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557
[TBL] [Abstract][Full Text] [Related]
3. Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant.
Vassilieva EV; Wang BZ; Vzorov AN; Wang L; Wang YC; Bozja J; Xu R; Compans RW
mBio; 2011; 2(1):e00328-10. PubMed ID: 21325038
[TBL] [Abstract][Full Text] [Related]
4. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles.
Cheng LF; Wang F; Zhang L; Yu L; Ye W; Liu ZY; Ying QK; Wu XA; Xu ZK; Zhang FL
Front Cell Infect Microbiol; 2016; 6():185. PubMed ID: 28066721
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.
Skountzou I; Quan FS; Gangadhara S; Ye L; Vzorov A; Selvaraj P; Jacob J; Compans RW; Kang SM
J Virol; 2007 Feb; 81(3):1083-94. PubMed ID: 17108046
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
Dong Y; Ma T; Zhang X; Ying Q; Han M; Zhang M; Yang R; Li Y; Wang F; Liu R; Wu X
J Med Microbiol; 2019 Mar; 68(3):480-492. PubMed ID: 30657443
[TBL] [Abstract][Full Text] [Related]
8. TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines.
Hjelm BE; Kilbourne J; Herbst-Kralovetz MM
Hum Vaccin Immunother; 2014; 10(2):410-6. PubMed ID: 24280723
[TBL] [Abstract][Full Text] [Related]
9. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
10. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
[TBL] [Abstract][Full Text] [Related]
11. Modular virus-like particles for sublingual vaccination against group A streptococcus.
Seth A; Kong IG; Lee SH; Yang JY; Lee YS; Kim Y; Wibowo N; Middelberg AP; Lua LH; Kweon MN
Vaccine; 2016 Dec; 34(51):6472-6480. PubMed ID: 27866769
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
Okada E; Sasaki S; Ishii N; Aoki I; Yasuda T; Nishioka K; Fukushima J; Miyazaki J; Wahren B; Okuda K
J Immunol; 1997 Oct; 159(7):3638-47. PubMed ID: 9317164
[TBL] [Abstract][Full Text] [Related]
13. Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation.
Springer MJ; Ni Y; Finger-Baker I; Ball JP; Hahn J; DiMarco AV; Kobs D; Horne B; Talton JD; Cobb RR
Vaccine; 2016 Mar; 34(12):1452-8. PubMed ID: 26873053
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.
Yao Q
Res Initiat Treat Action; 2003; 8(2):20-1. PubMed ID: 12845773
[TBL] [Abstract][Full Text] [Related]
15. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.
Ying Q; Ma T; Cheng L; Zhang X; Truax AD; Ma R; Liu Z; Lei Y; Zhang L; Ye W; Zhang F; Xu Z; Shang L; Liu R; Wang F; Wu X
Oncotarget; 2016 Sep; 7(39):63488-63503. PubMed ID: 27542281
[TBL] [Abstract][Full Text] [Related]
16. Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses.
Patel JM; Kim MC; Vartabedian VF; Lee YN; He S; Song JM; Choi HJ; Yamanaka S; Amaram N; Lukacher A; Montemagno CD; Compans RW; Kang SM; Selvaraj P
Nanomedicine; 2015 Jul; 11(5):1097-107. PubMed ID: 25752855
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
Zhang L; Lu J; Chen Y; Shi F; Yu H; Huang C; Cui L; Shi Z; Jiao Y; Hu Y
Viruses; 2015 Aug; 7(8):4369-84. PubMed ID: 26248076
[TBL] [Abstract][Full Text] [Related]
18. Interleukin/chitosan (JY) adjuvant enhances the mucosal immunity of human papillomavirus 16 L1 virus-like particles in mice.
Ma F; Zhang Q; Zheng L
Biotechnol Lett; 2015 Apr; 37(4):773-7. PubMed ID: 25472872
[TBL] [Abstract][Full Text] [Related]
19. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
Jackson RJ; Worley M; Trivedi S; Ranasinghe C
Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
